|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, ran- domised, placebo-controlled, phase 3 trial显示文摘 | Grothey A Van Cutsem E Sobrero A | 2013 | Lancet2013，381，9863： | 1 |
| 2 | The Role of Tbx2 and Tbx3 in mammary development and tumorigenesis显示文摘 | Rowley M Grothey E Couch FJ | 2004 | J Mammary Gland Biol Neoplasia2004，9，2： | 1 |
| 3 | Regorafenib monotherapy for previously treated metastatic colorectal cancer(CORRECT):an international,multicentre,randomised,placebo-controlled,phase 3 trial显示文摘 | Grothey A Van Cutsem E Sobrero A | 2013 | Lancet2013，381，： | 1 |
| 4 | Regorafenib monotherapy for previously treated metastatic colorectal cancer(CORRECT) :an in- ternational, multicentre, randomised, placebo-controlled, phase 3 trial 显示文摘 | Grothey A Van Cutsem E Sobrero A | 2013 | Lancet2013，381，9863： | 1 |
| 5 | Regorafenib mo:L therapy for previously treated metastatic colorectal cancer: an i ternational, multicentre, randomised, placebo-controlled, ph 3 trial显示文摘 | Grothey A Van Cutsem E Sobrero A | 2013 | Lancet2013，381，9863： | 1 |
| 6 | Targeting angiogenesis= progress with anti-VEGF treatment with large molecules显示文摘 | Grothey A Galanis E | 2009 | Nat Rev Clin Oncol2009，6，： | 1 |
| 7 | Targeting angiogenesis: progress with anti-VEGF treatment with large molecules 显示文摘 | GROTHEY A GALANIS E | 2009 | Nat Rev Clin Oncol2009，6，9： | 1 |
| 8 | Management of adverse events and other practical considerations in patients receiving eapecitabine(Xeloda) 显示文摘 | Marse H van Cutsem E Grothey A | 2004 | Eur J Oneol Nuts2004，8，1： | 1 |
| 9 | Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT):an international,multicentre,randomised,placebo-controlled,phase 3 trial显示文摘 | Grothey A Van Cutsem E Sobrero A | 2013 | Lancet2013，381，9863： | 1 |
| 10 | The role of TBX2 and TBX3in mammary development and tumorigenesis 显示文摘 | Rowley M Grothey E Couch F J | 2004 | J MammaryGland Biol Neoplasia2004，9，2： | 1 |
| 11 | Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multi centre, randomised, placebo-controlled, phase 3 trial显示文摘 | Grothey A Van Cutsem E Sobrero A | 2013 | Lancet2013，381，9863： | 1 |
| 12 | Regorafenib monotherapy for previously treated metastatic colorectal cancer(correct) : an international, muhieentre,randomised, placebo-controlled,phase 3 trial 显示文摘 | Grothey A Van Cutsem E Sobrero A | 2013 | Lancet2013，381，： | 1 |
| 13 | Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT) : an international, muhicentre, randomised, placebo- controlled, phase 3 trial显示文摘 | Grothey A Van Cutsem E Sobrero A | 2013 | Lancet2013，381，9863： | 1 |
| 14 | Regorafenib monotherapyfor previously treated metastatic colorectal cancer (CORRECT): aninternational, multicentre, randomised, placebo-controlled, phase 3trial显示文摘 | Grothey A Cutsem E V Sobrero A | 2013 | The Lancet2013，381，9863： | 1 |
| 15 | Regorafenibmono- therapy for previously treated metastatic eolorectal cancer ( COR- RECT): an international, multicentre, randomised, placebo- controlled, phase 3 trial 显示文摘 | Grothey A Van Cutsem E Sobrero A | 2013 | Lancet2013，381，9863： | 1 |
| 16 | Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial 显示文摘 | Grothey A Van Cutsem E Sobrero A | 2013 | Lancet2013，381，9863： | 1 |
| 17 | The role of Tbx2 and Tbx3 in mammary development and tumorigenesis显示文摘 | Rowley M Grothey E Couch FJ | 2004 | J Mammary Gland Biol Neoplasia2004，9，2： | 1 |
| 18 | Targeting angiogenesis:progress with anti-VEGF treatment with large molecules显示文摘 | Grothey A Galanis E | 2009 | Nat Rev Clin Oncol2009，6，9： | 1 |
| 19 | Regorafenib monotherapy for previously treated metastatic colorectal cancer(CORRECT):an international,multicentre,randomised,placebo-controlled,phase 3 trial显示文摘 | Grothey A Van Cutsem E Sobrero A | 2013 | Lancet2013，381，： | 1 |
| 20 | Regorafenib monotherapy for previously treated metastatic colorectal cancer(COR-RECT):an international,multicentre,randomised,placebo-controlled,phase 3 trial显示文摘 | Grothey A Van Cutsem E Sobrero A | 2013 | Lancet2013，381，9863： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员